학술논문

Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 MAIA Study
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; OCT 3 2023, 46 p183-p184, 2p. Supplement: 5
Subject
Language
English
ISSN
22965262